Ceftaroline Fosamil Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Ceftaroline fosamil is a novel broad-spectrum cephalosporin approved by the EMA in 2012 for the treatment of adults with complicated skin and soft-tissue infections (cSSTIs) and community-acquired pneumonia (CAP) [18].Ceftaroline Fosamil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceftaroline Fosamil Nitroso Impurity 1 CAS NO:NA chemically represented as (Z)-2-(2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetamido)-2-(5-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-3-nitroso-3,6-dihydro-2H-1,3-thiazin-2-yl)acetate . Synchemia is the leading manufacturing and exporter of Ceftaroline Fosamil Nitroso Impurity 1 . We supply Ceftaroline Fosamil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141667 |
| CAS No | NA |
| Mol.F. | C10H9ClN2O2 |
| Mol.Wt. | 224.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141668 |
| CAS No | 2912492-21-6 |
| Mol.F. | C9H14N2O3 |
| Mol.Wt. | 198.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141669 |
| CAS No | NA |
| Mol.F. | C17H27N3O6 |
| Mol.Wt. | 369.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141670 |
| CAS No | NA |
| Mol.F. | C20H33N3O6 |
| Mol.Wt. | 411.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141671 |
| CAS No | NA |
| Mol.F. | C19H31N3O6 |
| Mol.Wt. | 397.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141672 |
| CAS No | NA |
| Mol.F. | C12H12F2N2O2 |
| Mol.Wt. | 254.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141673 |
| CAS No | NA |
| Mol.F. | C12H13F2N3O2 |
| Mol.Wt. | 269.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0141674 |
| CAS No | NA |
| Mol.F. | C15H21N3O |
| Mol.Wt. | 259.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141675 |
| CAS No | NA |
| Mol.F. | C19H25N3O3 |
| Mol.Wt. | 343.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141676 |
| CAS No | NA |
| Mol.F. | C15H15ClN4OS |
| Mol.Wt. | 334.82 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141677 |
| CAS No | NA |
| Mol.F. | C19H26N2O |
| Mol.Wt. | 298.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141678 |
| CAS No | NA |
| Mol.F. | C19H20N2O2 |
| Mol.Wt. | 308.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141679 |
| CAS No | NA |
| Mol.F. | C13H11N4OS.Cl |
| Mol.Wt. | 306.77 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141680 |
| CAS No | NA |
| Mol.F. | C15H15N4OS |
| Mol.Wt. | 299.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141681 |
| CAS No | NA |
| Mol.F. | C19H20N2O4 |
| Mol.Wt. | 340.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141682 |
| CAS No | NA |
| Mol.F. | C12H15FN2O2 |
| Mol.Wt. | 238.3 |
| INV STATUS | CUSTOM SYNTHESIS |